Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Razupenem in complicated skin and skin structure infections
NCT00671580Phase 2Completed
- Sponsor
- Protez Pharmaceuticals
- Start
- May 2008
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of razupenem in Skin and Skin Structure Infection (SSSI), sponsored by Protez Pharmaceuticals. Started May 2008; status: completed.
02
Drugs
razupenem
03
Conditions
Skin and Skin Structure Infection (SSSI)
Beyond the preview
Go deeper on NCT00671580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00671580.